EDGEWOOD, Md. -- Glucosamine/chondroitin sulfate dietary supplement CosaminDS was proven effective in the management of joint pain in the knee in a 93-patient randomized, placebo-controlled, peer reviewed, clinical study published in the September 2000 issue of Osteoarthritis and Cartilage. CosaminDS is manufactured and distributed by Nutramax Laboratories Inc.

The intervention group in the study received CosaminDS, comprised of low molecular weight chondroitin sulfate, glucosamine and manganese ascorbate. The group showed significant improvement in the management of joint pain in the knee. The response rate was 52 percent compared with a 28 percent response rate in the placebo group, according to Nutramax Laboratories. The principle investigator is Dr. Amal K. Das of Hendersonville Orthopedic Associates in Hendersonville, N.C.

The company noted that CosaminDS is the only glucosamine/chondroitin sulfate supplement sold in the United States that utilizes the 95 percent pure low molecular weight chondroitin sulfate used in the study. The identical chondroitin sulfate has been proven effective in numerous published European trials, according to Nutramax Laboratories.

"We are very proud of the results of this study," said Robert Henderson, P.D., president and chief executive officer of Nutramax Laboratories, who invented and patented the combination of glucosamine and chondroitin sulfate. "The publication of this study shows that we are indeed a different kind of dietary supplement company. In this largely unregulated industry, we have been challenging our competitors to adopt stricter manufacturing and quality control standards, but so far, we are a lonely voice in the wilderness."

Advertisement

An abstract of the study, "Efficacy of a combination of FCHG49 glucosamine hydrochloride and TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis" can be found on the Internet at http://www.harcourtinternational.com/journals/joca/previous.cfm?art=j oca.1999.0308.

COPYRIGHT 2000 Lebhar-Friedman, Inc.
COPYRIGHT 2000 Gale Group

Save

Print

Send

Link

Subscribe